Chakra Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.60 M
as on 06-07-2024
- Paid Up Capital ₹ 2.60 M
as on 06-07-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.70 Cr
as on 06-07-2024
- Satisfied Charges ₹ 9.07 M
as on 06-07-2024
- Revenue 12.31%
(FY 2022)
- Profit 52.47%
(FY 2022)
- Ebitda 12.60%
(FY 2022)
- Net Worth 193.23%
(FY 2022)
- Total Assets 25.31%
(FY 2022)
About Chakra Drugs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.60 M and a paid-up capital of Rs 2.60 M.
The company currently has active open charges totaling ₹1.70 Cr. The company has closed loans amounting to ₹9.07 M, as per Ministry of Corporate Affairs (MCA) records.
Selliah Setumadava and Setumadava Vasumathy serve as directors at the Company.
- CIN/LLPIN
U74999TN2017PTC117012
- Company No.
117012
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Madurai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Chakra Drugs Private Limited offer?
Chakra Drugs Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herb Leaves, Fresh Flowers, Plants & Trees, Indoor Plants, Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cosmetics, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Neem Cake Fertilizer, Edible Oil & Allied Products.
Who are the key members and board of directors at Chakra Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Setumadava Vasumathy  | Managing Director | 08-Jun-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Selliah Setumadava | Director | 08-Jun-2017 | Current |
Financial Performance of Chakra Drugs.
Chakra Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.31% increase. The company also saw a substantial improvement in profitability, with a 52.47% increase in profit. The company's net worth Soared by an impressive increase of 193.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chakra Drugs?
In 2022, Chakra Drugs had a promoter holding of 3.85% and a public holding of 96.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ve.R Tax Consultancy Private LimitedActive 18 years 8 monthsSetumadava Vasumathy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tamilnad Mercantile Bank Limited Creation Date: 30 Sep 2021 | ₹1.60 Cr | Open |
Tamilnad Mercantile Bank Limited Creation Date: 30 Sep 2021 | ₹0.11 M | Open |
Tamilnad Mercantile Bank Limited Creation Date: 30 Sep 2021 | ₹0.55 M | Open |
How Many Employees Work at Chakra Drugs?
Unlock and access historical data on people associated with Chakra Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chakra Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chakra Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
